NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy

E-ISSN： 1875-533x|18|12|1820-1831

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.12, 2011-04, pp. : 1820-1831

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological profiles of new orally active nonpeptide tachykinin NK 1 receptor antagonists

By Hosoki R. Yanagisawa M. Onishi Y. Yoshioka K. Otsuka M.

European Journal of Pharmacology, Vol. 341, Iss. 2, 1998-01 ,pp. : 235-241

Elsevier

Access to resources Recommend Favorite

The NK-1 Receptor: A New Target in Cancer Therapy

Current Drug Targets, Vol. 12, Iss. 6, 2011-06 ,pp. : 909-921

Bentham Science Publishers

Access to resources Recommend Favorite

A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists

Current Medicinal Chemistry, Vol. 17, Iss. 6, 2010-02 ,pp. : 504-516

Bentham Science Publishers

Access to resources Recommend Favorite

NK-1 Receptor Antagonists: A New Generation of Anticancer Drugs

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 7, 2012-06 ,pp. : 593-599

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and pharmacological evaluation of new cysLT 1 receptor antagonists

By Griera R. Armengol M. Reyes A. Alvarez M. Palomer A. Cabre F. Pascual J. Garcia M. Mauleon D.

European Journal of Medicinal Chemistry, Vol. 32, Iss. 7, 1997-07 ,pp. : 547-570

Elsevier

Access to resources Recommend Favorite